A genetic variant near GATA3 implicated in inherited susceptibility and etiology of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS)

被引:26
作者
Na, Rong [1 ,2 ,3 ]
Helfand, Brian T. [1 ,4 ]
Chen, Haitao [5 ]
Conran, Carly A. [1 ]
Crawford, Susan E. [1 ]
Hayward, Simon W. [1 ]
Tammela, Teuvo L. J. [6 ,7 ]
Hoffman-Bolton, Judy [8 ]
Zheng, Siqun L. [1 ]
Walsh, Patrick C. [9 ,10 ]
Schleutker, Johanna [11 ]
Platz, Elizabeth A. [8 ]
Isaacs, William B. [9 ,10 ,12 ]
Xu, Jianfeng [1 ,2 ]
机构
[1] NorthShore Univ HealthSyst, Program Personalized Canc Care, 1001 Univ Pl, Evanston, IL 60201 USA
[2] Fudan Univ, Fudan Inst Urol, Huashan Hosp, Shanghai, Peoples R China
[3] Fudan Univ, Shanghai Med Coll, Shanghai, Peoples R China
[4] NorthShore Univ HealthSyst, Dept Surg, Evanston, IL USA
[5] Fudan Univ, Sch Publ Hlth, Shanghai, Peoples R China
[6] Tampere Univ Hosp, Dept Urol, Tampere, Finland
[7] Univ Tampere, Sch Med, Tampere, Finland
[8] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[9] Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21205 USA
[10] Johns Hopkins Univ, Sch Med, James Buchanan Brady Urol Inst, Baltimore, MD USA
[11] Univ Turku, Dept Med Biochem & Genet, Turku, Finland
[12] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA
关键词
BPH; genome-wide association study; LUTS; GENOME-WIDE ASSOCIATION; COMBINATION THERAPY; CANCER; POLYMORPHISMS; POPULATION; METAANALYSIS; PATHWAY; DISEASE; GROWTH; TRIAL;
D O I
10.1002/pros.23380
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Benign prostatic hyperplasia (BPH) and associated lower urinary tract symptoms (LUTS) are common conditions. Little is known about their etiologies except that studies have suggested a substantial heritable component. Our objective is to provide a comprehensive, genome-wide evaluation of inherited risks and possible mechanisms of etiology in BPH. Methods: We performed a three-stage, genome-wide association study (GWAS) of men from three independent populations, the REduction by DUtasteride of prostate Cancer Events (REDUCE) trial, the CLUE II cohort, and a Finnish hospital-based population. DNA samples were genotyped using the Illumina HumanOmniExpress BeadChip in REDUCE and CLUE II, and using the Sequenom iPLEX system for the confirmation stage in the Finnish population. A logistic regression model was used to evaluate the association between each SNP and BPH/LUTS. Results: Fourteen SNPs reached P < 5.0 x 10(-4) in the meta-analysis of the two GWASs(CLUE II and REDUCE). A total of 773 SNPs were chosen for the confirmation step in the Finish cohort. Only one SNP (rs17144046) located similar to 489 kb downstream of GATA3 remained significant after correction for multiple testing (P < 6.5 x 10(-5)). This SNP marginally reached the GWAS significance level after performing a meta-analysis of the three stages (P-meta = 8.89 x 10(-7)). Expression quantitative trait loci eQTL) analyses showed that the risk allele (G) of rs17144046 was significantly associated with increased expression of GATA3 (P = 0.017). Reported studies indicated a close correlation between GATA3 and BPH pathogenesis and progression. Conclusions: Rs17144046 located near GATA3 was significantly associated with BPH/LUTS in three independent populations, but did not reach a stringent GWAS significance level. Genetic variants of GATA3 may play a role in the inherited susceptibility and etiology of BPH/LUTS. Further research in this area is needed.
引用
收藏
页码:1213 / 1220
页数:8
相关论文
共 30 条
[1]   Heritability of Lower Urinary Tract Symptoms in Men: A Twin Study [J].
Afari, Niloofar ;
Gasperi, Marianna ;
Forsberg, Christopher W. ;
Goldberg, Jack ;
Buchwald, Dedra ;
Krieger, John N. .
JOURNAL OF UROLOGY, 2016, 196 (05) :1486-1491
[2]   Pathophysiology of allergic inflammation [J].
Barnes, Peter J. .
IMMUNOLOGICAL REVIEWS, 2011, 242 :31-50
[3]  
BARRY MJ, 1990, UROL CLIN N AM, V17, P495
[4]   Correlation between prostate volume and single nucleotide polymorphisms implicated in the steroid pathway [J].
Cornu, Jean-Nicolas ;
Audet-Walsh, Etienne ;
Drouin, Sarah ;
Bigot, Pierre ;
Valeri, Antoine ;
Fournier, Georges ;
Azzouzi, Abdel-Rahmene ;
Roupret, Morgan ;
Cormier, Luc ;
Chanock, Stephen ;
Guillemette, Chantal ;
Cussenot, Olivier ;
Levesque, Eric ;
Cancel-Tassin, Geraldine .
WORLD JOURNAL OF UROLOGY, 2017, 35 (02) :293-298
[5]   GATA3 inhibits breast cancer growth and pulmonary breast cancer metastasis [J].
Dydensborg, A. B. ;
Rose, A. A. N. ;
Wilson, B. J. ;
Grote, D. ;
Paquet, M. ;
Giguere, V. ;
Siegel, P. M. ;
Bouchard, M. .
ONCOGENE, 2009, 28 (29) :2634-2642
[6]  
GLYNN RJ, 1985, AM J EPIDEMIOL, V121, P78
[7]   PPARγ: A molecular link between systemic metabolic disease and benign prostate hyperplasia [J].
Jiang, Ming ;
Strand, Douglas W. ;
Franco, Omar E. ;
Clark, Peter E. ;
Hayward, Simon W. .
DIFFERENTIATION, 2011, 82 (4-5) :220-236
[8]   Gata3 loss leads to embryonic lethality due to noradrenaline deficiency of the sympathetic nervous system [J].
Lim, KC ;
Lakshmanan, G ;
Crawford, SE ;
Gu, Y ;
Grosveld, F ;
Engel, JD .
NATURE GENETICS, 2000, 25 (02) :209-212
[9]   Association of variants in genes related to the immune response and obesity with BPH in CLUE II [J].
Lopez, D. S. ;
Peskoe, S. B. ;
Tsilidis, K. K. ;
Hoffman-Bolton, J. ;
Helzlsouer, K. J. ;
Isaacs, W. B. ;
Smith, M. W. ;
Platz, E. A. .
PROSTATE CANCER AND PROSTATIC DISEASES, 2014, 17 (04) :353-358
[10]   European randomized study of prostate cancer screening:: first-year results of the Finnish trial [J].
Määttänen, L ;
Auvinen, A ;
Stenman, UH ;
Rannikko, S ;
Tammela, T ;
Aro, J ;
Juusela, H ;
Hakama, M .
BRITISH JOURNAL OF CANCER, 1999, 79 (7-8) :1210-1214